What does CUSIP 00507W107 represent in this 13F holders report?

CUSIP 00507W107 is the security identifier for ATNM - ACTINIUM PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held ATNM - ACTINIUM PHARMACEUTICALS INC - COM in Q1 2018?

35 institutional investors reported ATNM - ACTINIUM PHARMACEUTICALS INC - COM for Q1 2018. Use the holders table for investor-level position and value details.

ACTINIUM PHARMACEUTICALS INC - COM (ATNM)

CUSIP: 00507W107

Q1 2018 13F Holders as of 31 Mar 2018

Security type / class: Equity / COM
Total 13F shares: 22,526,710
Total 13F value: $8,223,000
Share change: +12,893,798
SEC-reported price per share: $0.37
Number of holders: 35
Value change: +$4,689,851
Number of buys: 19
Number of sells: 12

Security key

00507W107

Report period

Q1 2018

Institutions

Top holders

ATNM full security history Ownership snapshot Full 13F holder table Actinium Pharmaceuticals, Inc. SEC filings Actinium Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ATNM - ACTINIUM PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

0/15

Latest evidence

31 Dec 2017

13F Highest disclosed value: $2,962,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $2.96M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Disclosed position value Top 5

ARMISTICE CAPITAL, LLC $2.96M

VANGUARD GROUP INC $1.65M

CREDIT SUISSE AG/ $538K

BlackRock Finance, Inc. $437K

GEODE CAPITAL MANAGEMENT, LLC $126K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$2,962,000 4,464,000 shares	—	31 Dec 2017
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$1,654,000 2,492,263 shares	—	31 Dec 2017
CREDIT SUISSE AG/	13F Company 13F	— denominator unverified	$538,000 810,200 shares	—	31 Dec 2017
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$437,000 657,324 shares	—	31 Dec 2017
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$126,000 191,249 shares	—	31 Dec 2017
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$114,000 172,300 shares	—	31 Dec 2017

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

22,526,710

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q1 2018 value	Q1 2018 value	Value change	Value Chg %